glp 1 suicidal thoughts Understanding the link between GLP-1 therapies and suicidal ideation using real-world data

Glucagon-Like Peptide-1 Receptor Agonists and Risk for Suicidal Ideation and Behaviors in U.S. Older Adults With Type 2 Diabetes: A Target Trial Emulation Study: Annals of Internal Medicine: Vol 177, No 8

23.43

★★★★☆4.8 (126)

Adolescents treated for obesity with GLP-1 drugs had lower risk of suicidal thoughts, study finds | HealthWatch

22.72

★★★★★4.9 (98)

Suicide and suicide attempt in users of GLP-1 receptor agonists: a nationwide case-time-control study

23.62

★★★★★5.0 (157)

Australia's medicines regulator has issued a safety warning over the risk of suicidal thoughts and behaviour linked to drugs known as GLP-1 receptor agonists, including Ozempic. https://www.theage.com.au/healthcare/watchdog-issues-safety-alert-for

27.60

★★★★★4.7 (84)

FDA Moves To Remove Suicide Warnings From GLP-1 Weight Loss Drugs

27.01

★★★★★4.9 (203)

The U.S. FDA on Tuesday asked drugmakers to remove warnings about a potential risk of suicidal thoughts from popular GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Saxenda, and Eli Lilly's Zepbound

28.21

★★★★★5.0 (176)

GLP1 drugs, formally known as Glucagon-like peptide-1 (GLP-1) agonists, were created as a diabetic drug due to their ability to stimulate the body to produce insulin. Recently they have gained

22.11

★★★★★4.8 (132)